During HSV-1 neuronal latency, only one viral gene is consistently observed to be expressed at high levels (6, 39). This LAT (latency-associated transcript) gene has a powerful promoter that is active in most cell types (23,27,37). LAT Ϫ viruses appear to be unimpaired during acute infection (35). Thus, insertion of a foreign gene under the LAT promoter in place of the structural portion of LAT can produce a useful recombinant vector. In this study, we inserted the gene for murine interleukin-4 (IL-4) into both copies of the LAT gene (one in each viral long repeat), under control of the LAT promoter, in place of the 5Ј end of the LAT gene. The recombinant virus carrying this gene, HSV-IL-4, expressed high levels of IL-4 and allowed us to examine the effect of high exogenous IL-4 levels on HSV-1 pathogenicity in mice.IL-4 is a pleiotropic lymphokine synthesized primarily by activated T helper lymphocytes (26, 34). IL-4 enhances the development of TH2 responses and inhibits TH1 development (1,21,43). TH2 cells are involved in humoral (antibody-mediated) immunity and produce IL-4, IL-5, and IL-10 (31, 34). IL-4 is also an important regulator of isotype switching and the stimulation of immunoglobulin E production in B lymphocytes (8-10).Different reports have provided contradictory evidence suggesting that IL-4 may have either protective or detrimental effects during viral infection (4,11,12,24,29,42). Recently, a recombinant mousepox virus expressing IL-4 was reported to have greatly increased pathogenicity in infected mice (22). Even vaccinated mice were not protected against the recombinant virus.In contrast to the results with the IL-4-expressing mousepox virus, we report here that a recombinant HSV-1 expressing IL-4 had decreased pathogenicity. We found that (i) despite wild-type (wt) replication in tissue culture, HSV-IL-4 replication in mouse eyes and brains was decreased compared to that of wt virus; (ii) HSV-IL-4 infection did not kill any mice; and (iii) in mice depleted of CD4 ϩ T cells, HSV-IL-4 had wt pathogenicity, suggesting that a CD4ϩ -T-cell response was involved in protecting mice against HSV-IL-4 infection.
MATERIALS AND METHODS
Viruses and cells.Triple-plaque-purified wt McKrae and recombinant dLAT2903 strains of HSV-1 have been described previously (35). Rabbit skin (RS) cells, used for preparation of virus stocks, culturing mouse tear films, and determining growth kinetics, were grown in Eagle's minimal essential medium supplemented with 5% fetal calf serum. L929 cells, used for enzyme-linked immunosorbent assay titers, were grown in RPMI 1640 supplemented with 10% fetal calf serum.Mice. Inbred BALB/c, homozygous BALB/c-IL-4 Ϫ/Ϫ , and C57BL/6 mice (Jackson Laboratory, Bar Harbor, Maine) were used. All mice used were between 5 and 8 weeks old.Construction of IL-4 plasmid. The parental virus for this construct was dLAT2903, a mutant of HSV-1 strain McKrae in which the region of LAT from Ϫ161 to ϩ1667 relative to the LAT transcription start site (EcoRV-HpaI) was deleted from both copies of LAT (3...